Azenta, Inc. (AZTA)
USD 49.65
(7.21%)
USD 49.65
(7.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 263.14 Million USD | 2.96% |
| 2022 | 255.58 Million USD | 4.83% |
| 2021 | 243.8 Million USD | -35.84% |
| 2020 | 380.02 Million USD | 19.97% |
| 2019 | 316.75 Million USD | 28.72% |
| 2018 | 246.08 Million USD | -7.97% |
| 2017 | 267.4 Million USD | 35.0% |
| 2016 | 198.08 Million USD | 4.75% |
| 2015 | 189.1 Million USD | 13.01% |
| 2014 | 167.33 Million USD | 14.63% |
| 2013 | 145.98 Million USD | -15.85% |
| 2012 | 173.48 Million USD | -22.21% |
| 2011 | 223.02 Million USD | 34.11% |
| 2010 | 166.29 Million USD | 2873.43% |
| 2009 | -5.99 Million USD | -104.73% |
| 2008 | 126.82 Million USD | -42.24% |
| 2007 | 219.59 Million USD | -10.29% |
| 2006 | 244.78 Million USD | 50.36% |
| 2005 | 162.8 Million USD | -20.32% |
| 2004 | 204.32 Million USD | 97.1% |
| 2003 | 103.66 Million USD | 24.83% |
| 2002 | 83.04 Million USD | -45.5% |
| 2001 | 152.38 Million USD | -5.61% |
| 2000 | 161.44 Million USD | 187.78% |
| 1999 | 56.1 Million USD | 57.58% |
| 1998 | 35.6 Million USD | 8.54% |
| 1997 | 32.8 Million USD | -19.8% |
| 1996 | 40.9 Million USD | 108.67% |
| 1995 | 19.6 Million USD | 100.0% |
| 1994 | 9.8 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 61.51 Million USD | -9.59% |
| 2024 Q3 | 69.05 Million USD | 21.73% |
| 2024 Q2 | 56.73 Million USD | -7.77% |
| 2023 Q3 | 68 Million USD | 27.74% |
| 2023 FY | 263.14 Million USD | 2.96% |
| 2023 Q1 | 73.86 Million USD | 27.1% |
| 2023 Q4 | 68.03 Million USD | 0.04% |
| 2023 Q2 | 53.23 Million USD | -27.93% |
| 2022 Q2 | 70.82 Million USD | 5.64% |
| 2022 FY | 255.58 Million USD | 4.83% |
| 2022 Q1 | 67.04 Million USD | 1.36% |
| 2022 Q4 | 58.11 Million USD | -2.49% |
| 2022 Q3 | 59.6 Million USD | -15.85% |
| 2021 Q2 | 127.27 Million USD | 12.5% |
| 2021 FY | 243.8 Million USD | -35.84% |
| 2021 Q4 | 66.14 Million USD | -54.2% |
| 2021 Q3 | 144.4 Million USD | 13.46% |
| 2021 Q1 | 113.12 Million USD | 1.04% |
| 2020 Q4 | 111.96 Million USD | 20.67% |
| 2020 Q1 | 84.98 Million USD | 5.38% |
| 2020 Q3 | 92.78 Million USD | 2.78% |
| 2020 FY | 380.02 Million USD | 19.97% |
| 2020 Q2 | 90.28 Million USD | 6.23% |
| 2019 Q4 | 80.65 Million USD | -3.42% |
| 2019 Q1 | 72.08 Million USD | 15.11% |
| 2019 Q3 | 83.51 Million USD | 3.72% |
| 2019 Q2 | 80.51 Million USD | 11.7% |
| 2019 FY | 316.75 Million USD | 28.72% |
| 2018 Q2 | 84.22 Million USD | 11.98% |
| 2018 FY | 246.08 Million USD | -7.97% |
| 2018 Q1 | 75.21 Million USD | 1.14% |
| 2018 Q3 | 89.22 Million USD | 5.93% |
| 2018 Q4 | 62.62 Million USD | -29.81% |
| 2017 FY | 267.4 Million USD | 35.0% |
| 2017 Q3 | 71.57 Million USD | 10.92% |
| 2017 Q4 | 74.36 Million USD | 3.9% |
| 2017 Q2 | 64.52 Million USD | 13.31% |
| 2017 Q1 | 56.94 Million USD | 0.67% |
| 2016 FY | 198.08 Million USD | 4.75% |
| 2016 Q3 | 54.16 Million USD | 15.73% |
| 2016 Q2 | 46.8 Million USD | 15.4% |
| 2016 Q1 | 40.55 Million USD | -23.2% |
| 2016 Q4 | 56.56 Million USD | 4.43% |
| 2015 FY | 189.1 Million USD | 13.01% |
| 2015 Q3 | 51.18 Million USD | 11.22% |
| 2015 Q2 | 46.02 Million USD | 17.75% |
| 2015 Q4 | 52.8 Million USD | 3.16% |
| 2015 Q1 | 39.08 Million USD | -5.59% |
| 2014 Q1 | 44.65 Million USD | 10.18% |
| 2014 Q2 | 44.29 Million USD | -0.79% |
| 2014 Q4 | 41.4 Million USD | 1.61% |
| 2014 Q3 | 40.74 Million USD | -8.02% |
| 2014 FY | 167.33 Million USD | 14.63% |
| 2013 Q2 | 36.61 Million USD | 25.56% |
| 2013 FY | 145.98 Million USD | -15.85% |
| 2013 Q4 | 40.52 Million USD | 2.12% |
| 2013 Q3 | 39.68 Million USD | 8.4% |
| 2013 Q1 | 29.15 Million USD | -24.47% |
| 2012 Q2 | 48.28 Million USD | 19.64% |
| 2012 Q3 | 46.24 Million USD | -4.23% |
| 2012 Q4 | 38.6 Million USD | -16.51% |
| 2012 FY | 173.48 Million USD | -22.21% |
| 2012 Q1 | 40.35 Million USD | -14.24% |
| 2011 Q2 | 61.67 Million USD | 7.6% |
| 2011 FY | 223.02 Million USD | 34.11% |
| 2011 Q4 | 47.05 Million USD | -17.4% |
| 2011 Q1 | 57.31 Million USD | 3.85% |
| 2011 Q3 | 56.97 Million USD | -7.63% |
| 2010 Q1 | 26.24 Million USD | 121.26% |
| 2010 FY | 166.29 Million USD | 2873.43% |
| 2010 Q2 | 38.95 Million USD | 48.4% |
| 2010 Q3 | 45.9 Million USD | 17.86% |
| 2010 Q4 | 55.19 Million USD | 20.24% |
| 2009 FY | -5.99 Million USD | -104.73% |
| 2009 Q4 | 11.86 Million USD | 234.14% |
| 2009 Q3 | 3.55 Million USD | 112.77% |
| 2009 Q1 | 6.38 Million USD | -72.33% |
| 2009 Q2 | -27.79 Million USD | -535.13% |
| 2008 FY | 126.82 Million USD | -42.24% |
| 2008 Q4 | 23.08 Million USD | -20.01% |
| 2008 Q3 | 28.85 Million USD | -20.81% |
| 2008 Q2 | 36.43 Million USD | -5.23% |
| 2008 Q1 | 38.44 Million USD | -3.85% |
| 2007 FY | 219.59 Million USD | -10.29% |
| 2007 Q4 | 39.98 Million USD | -30.38% |
| 2007 Q3 | 57.43 Million USD | -8.09% |
| 2007 Q2 | 62.49 Million USD | 4.7% |
| 2007 Q1 | 59.68 Million USD | -22.11% |
| 2006 Q1 | 36.93 Million USD | 0.39% |
| 2006 FY | 244.78 Million USD | 50.36% |
| 2006 Q3 | 71.48 Million USD | 19.66% |
| 2006 Q2 | 59.74 Million USD | 61.75% |
| 2006 Q4 | 76.62 Million USD | 7.2% |
| 2005 Q3 | 40.08 Million USD | -8.0% |
| 2005 Q1 | 41.68 Million USD | -36.18% |
| 2005 FY | 162.8 Million USD | -20.32% |
| 2005 Q4 | 36.79 Million USD | -8.22% |
| 2005 Q2 | 43.57 Million USD | 4.53% |
| 2004 Q2 | 50.91 Million USD | 68.33% |
| 2004 Q4 | 65.3 Million USD | 12.87% |
| 2004 Q1 | 30.24 Million USD | 11.83% |
| 2004 Q3 | 57.86 Million USD | 13.65% |
| 2004 FY | 204.32 Million USD | 97.1% |
| 2003 Q1 | 24.37 Million USD | 46.13% |
| 2003 FY | 103.66 Million USD | 24.83% |
| 2003 Q4 | 27.04 Million USD | -1.99% |
| 2003 Q3 | 27.59 Million USD | 11.93% |
| 2003 Q2 | 24.65 Million USD | 1.14% |
| 2002 FY | 83.04 Million USD | -45.5% |
| 2002 Q1 | 24.11 Million USD | 65.49% |
| 2002 Q2 | 20.04 Million USD | -16.88% |
| 2002 Q3 | 26.67 Million USD | 33.07% |
| 2002 Q4 | 16.68 Million USD | -37.46% |
| 2001 Q2 | 49.19 Million USD | -3.73% |
| 2001 Q4 | 14.57 Million USD | -66.13% |
| 2001 Q3 | 43.02 Million USD | -12.54% |
| 2001 FY | 152.38 Million USD | -5.61% |
| 2001 Q1 | 51.09 Million USD | -0.45% |
| 2000 Q4 | 51.32 Million USD | 28.59% |
| 2000 Q1 | 26.3 Million USD | 33.5% |
| 2000 Q3 | 39.91 Million USD | 8.73% |
| 2000 Q2 | 36.71 Million USD | 39.58% |
| 2000 FY | 161.44 Million USD | 187.78% |
| 1999 FY | 56.1 Million USD | 57.58% |
| 1999 Q4 | 19.7 Million USD | 40.71% |
| 1999 Q3 | 14 Million USD | 15.7% |
| 1999 Q2 | 12.1 Million USD | 16.35% |
| 1999 Q1 | 10.4 Million USD | -38.46% |
| 1998 Q2 | 2.5 Million USD | -74.23% |
| 1998 Q1 | 9.7 Million USD | -19.17% |
| 1998 FY | 35.6 Million USD | 8.54% |
| 1998 Q4 | 16.9 Million USD | 164.06% |
| 1998 Q3 | 6.4 Million USD | 156.0% |
| 1997 Q3 | 9 Million USD | 63.64% |
| 1997 Q2 | 5.5 Million USD | -14.06% |
| 1997 Q4 | 12 Million USD | 33.33% |
| 1997 FY | 32.8 Million USD | -19.8% |
| 1997 Q1 | 6.4 Million USD | -41.28% |
| 1996 Q4 | 10.9 Million USD | -2.68% |
| 1996 FY | 40.9 Million USD | 108.67% |
| 1996 Q3 | 11.2 Million USD | 8.74% |
| 1996 Q2 | 10.3 Million USD | -38.69% |
| 1996 Q1 | 16.8 Million USD | 15.86% |
| 1995 FY | 19.6 Million USD | 100.0% |
| 1995 Q4 | 14.5 Million USD | 14.17% |
| 1995 Q2 | 10 Million USD | 19.05% |
| 1995 Q3 | 12.7 Million USD | 27.0% |
| 1995 Q1 | 8.4 Million USD | 0.0% |
| 1994 FY | 9.8 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -367.347% |
| AngioDynamics, Inc. | 154.69 Million USD | -70.099% |
| AtriCure, Inc. | 300.37 Million USD | 12.395% |
| Avinger, Inc. | 2 Million USD | -13037.294% |
| BioLife Solutions, Inc. | 46.75 Million USD | -462.842% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 88.84% |
| Daxor Corporation | 1.1 Million USD | -23747.241% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -2798.337% |
| Femasys Inc. | 691.9 Thousand USD | -37931.452% |
| GlucoTrack, Inc. | -13 Thousand USD | 2024253.846% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -332.327% |
| Hologic, Inc. | 2.22 Billion USD | 88.188% |
| ICU Medical, Inc. | 739.87 Million USD | 64.434% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 94.436% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -1474.908% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -107.117% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 220616.387% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 220616.387% |
| Masimo Corporation | 1 Billion USD | 73.778% |
| Microbot Medical Inc. | -106 Thousand USD | 248345.283% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -695.105% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 54.932% |
| Nephros, Inc. | 8.4 Million USD | -3030.756% |
| NovoCure Limited | 381.05 Million USD | 30.945% |
| NEXGEL, Inc. | 619 Thousand USD | -42410.501% |
| NEXGEL, Inc. | 619 Thousand USD | -42410.501% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 47257.706% |
| OraSure Technologies, Inc. | 179.42 Million USD | -46.661% |
| Pro-Dex, Inc. | 14.55 Million USD | -1708.398% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 21901.16% |
| Predictive Oncology Inc. | 1.14 Million USD | -22875.7% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -4438.636% |
| QuidelOrtho Corporation | 1.49 Billion USD | 82.392% |
| Repligen Corporation | 315.22 Million USD | 16.524% |
| Sanara MedTech Inc. | 57.13 Million USD | -360.541% |
| STAAR Surgical Company | 252.65 Million USD | -4.152% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 29624.891% |
| Utah Medical Products, Inc. | 30.03 Million USD | -776.024% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 87.385% |
| Jin Medical International Ltd. | 6.78 Million USD | -3778.356% |